Alivus Life Sciences Cash Flow Annual

Trade
BSE: 543322 | NSE: ALIVUS | ISIN: INE03Q201024 | Sector: Biotechnology & Drugs
1,035.50 +5.20 (0.50%)Updated : 25 Apr 2025
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 631.29628.61564.93470.94
Depreciation/ Depletion 53.4542.0937.8833.39
Non- Cash Items 37.8418.2939.89100.35
Changesin Working Capital -309.06-382.99-45.11-216.57
Cashfrom Operating Activities 413.52306.01597.59388.11
Capital Expenditures -128.97-162.80-132.17-67.99
Other Investing Cash Flow Items Total 12.4916.059.94-0.74
Cashfrom Investing Activities -116.48-146.75-122.23-68.73
Financing Cash Flow Items -1.55-0.55-0.07-
Total Cash Dividends Paid -275.69-385.92-128.65-
Issuance( Retirement)of Debt Net -2.21-1.13-961.92-213.78
Cashfrom Financing Activities -279.44-387.59-78.80-213.78
Net Changein Cash 17.59-228.33396.56105.60
Cash Interest Paid 1.550.550.07-
Cash Taxes Paid 162.96153.57138.17108.56
period Length 12.0012.0012.0012.00
period Type ----
Issuance( Retirement)of Stock Net --1,011.850.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,461.50+15.40(1.06%)
1,480.20+8.90(0.60%)
1,165.30-42.00 (-3.48%)
2,045.35-60.05 (-2.85%)